Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy (Record no. 29143)

MARC details
000 -LEADER
fixed length control field 03065nam a22002657a 4500
001 - CONTROL NUMBER
control field 20241012101007.0
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20241012101344.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 241012b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 978-3-030-56823-8
International Standard Book Number 978-3-030-56824-5 (eBook)
040 ## - CATALOGING SOURCE
Transcribing agency ddc
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.994 SUA
100 ## - MAIN ENTRY--PERSONAL NAME
Fuller form of name Maria E. Suarez-Almazor
245 ## - TITLE STATEMENT
Title Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy
Remainder of title A Handbook for Diagnosis and Management.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Department of Health Services Research University of Texas MD Anderson Cancer Center Houston, TX USA |
Name of publisher, distributor, etc. Springer Nature Switzerland AG |
Date of publication, distribution, etc. 2021.
300 ## - PHYSICAL DESCRIPTION
Extent 361 Pages
Extent Includes References
520 ## - SUMMARY, ETC.
Summary, etc. <br/><br/>With the increasing use of immune checkpoint inhibitors (ICI) across various cancers, the trends for indication at earlier stages, and the use of combination immunotherapy, the frequency of ICI-induced immune-related adverse events (irAE) is expected to grow substantially. Management of these irAE is challenging as it requires not only consideration of the toxicity but also risk-benefit ratios with respect to the primary cancer. Several rheumatic irAE have been reported with ICI therapy including arthritis, myositis, polymyalgia-like syndromes, sicca/Sjogren-like manifestations, and several other less common systemic autoimmune features commonly associated with connective tissue disease.<br/><br/><br/><br/>This handbook provides clinicians with a comprehensive overview of the management of rheumatic irAE that develop from cancer immunotherapy. It focuses on the irAE seen with ICI, the most frequently used agents in treating cancer. It provides an overview of cancer immunology, immunotoxicity, and immunotherapies such as ICI, cytokine-based therapy, and CART. It examines the epidemiology, clinical manifestations, diagnosis, differential diagnosis, and treatment of a variety of rheumatic immune-related adverse events arising from these therapies. Chapters also cover cancer immunotherapy in patients with preexisting rheumatic diseases such as inflammatory arthritis and other connective tissue disorders. The book helps clinicians to distinguish the current types of cancer immunotherapy and general toxicity patterns, recognize and diagnose rheumatic clinical syndromes, understand the pathogenesis of irAE, and consider risk–benefit ratios when managing patients with rheumatic irAE.<br/><br/><br/>Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy is an essential resource for physicians and related professionals, residents, fellows, graduate students and nurses alike in rheumatology, clinical immunology, oncology, and internal medicine.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Immunology, Medical / Clinical Medicine, Medical / Immunology, Medical / Oncology / General, Medical / Rheumatology, Oncology, Rheumatology, Cancer -- Immunotherapy -- Complications, Immunologic diseases, Rheumatism.
700 ## - ADDED ENTRY--PERSONAL NAME
Fuller form of name Leonard H. Calabrese
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/978-3-030-56824-5 ">https://doi.org/10.1007/978-3-030-56824-5 </a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Suppress in OPAC
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total checkouts Full call number Barcode Date last seen Uniform resource identifier Price effective from Koha item type
          MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO 10/12/2024   616.994 SUA 20241012101007.0 10/12/2024 https://doi.org/10.1007/978-3-030-56824-5 10/12/2024 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024